Abstract
Hereditary angioedema (HAE) is a rare disease affecting approximately 1 in 50,000 people and presents with recurrent cutaneous and mucosal membrane swelling. The result is recurrent angioedema, intermittent abdominal obstruction and pain, and airway swelling. Though death is rare in patients diagnosed and on therapy, upper airway swelling can be fatal. Disability and absenteeism secondary to the frequent attacks lasting up to 3 days can limit quality of life and education and occupational stability. Multiple therapies have been approved in the last decade and have made drastic improvements in this orphan disease. This chapter will discuss epidemiology, signs and symptoms, differential diagnosis, diagnosis, treatment, and management of the HAE patient.
This is a preview of subscription content, log in via an institution to check access.
References
Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71(4):206–15.
Betschel S, Badiou J, Binkley K, Hébert J, Kanani A, Keith P, et al. Canadian hereditary angioedema guideline. Allergy Asthma Clin Immunol. 2014;10(1):50. https://doi.org/10.1186/1710-1492-10-50.
Bonnaud I, Rouaud V, Guyot M, Debiais S, Saudeau D, de Toffol B, et al. Exceptional stroke-like episodes in a patient with type I autosomal angioedema. Neurology. 2012;78(8):598–9. https://doi.org/10.1212/WNL.0b013e318247ca58.
Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med. 2003a;114(4):294–8.
Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med. 2003b;163(10):1229–35. https://doi.org/10.1001/archinte.163.10.1229.
Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267–74. https://doi.org/10.1016/j.amjmed.2005.09.064.
Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol. 2007a;119(6):1497–503. https://doi.org/10.1016/j.jaci.2007.02.012.
Bork K, Gül D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med. 2007b;120(11):987–92. https://doi.org/10.1016/j.amjmed.2007.08.021.
Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130(3):692–7. https://doi.org/10.1016/j.jaci.2012.05.055.
Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008;199(5):484.e1–4. https://doi.org/10.1016/j.ajog.2008.04.034.
Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B, et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. Ann Allergy Asthma Immunol. 2008;100(1 Suppl 2):S30–40.
Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, et al. 2010 international consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010;6(1):24. https://doi.org/10.1186/1710-1492-6-24.
Brickman CM, Tsokos GC, Balow JE, Lawley TJ, Santaella M, Hammer CH, et al. Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J Allergy Clin Immunol. 1986;77(5):749–57.
Caballero T, Farkas H, Bouillet L, Bowen T, Gompel A, Fagerberg C, et al. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol. 2012;129(2):308–20. https://doi.org/10.1016/j.jaci.2011.11.025.
Cancian M, Vettore G, Realdi G. An uncommon cause of acute pancreatitis. Hereditary angioedema-induced acute pancreatitis. Gastroenterology. 2011;140(1):33, 370. https://doi.org/10.1053/j.gastro.2010.02.064.
Chinniah N, Katelaris CH. Hereditary angioedema and pregnancy. Aust N Z J Obstet Gynaecol. 2009;49(1):2–5. https://doi.org/10.1111/j.1479-828X.2008.00945.x.
Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy. 2012;67(2):147–57. https://doi.org/10.1111/j.1398-9995.2011.02751.x.
Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014a;69(5):602–16. https://doi.org/10.1111/all.12380.
Cicardi M, Bellis P, Bertazzoni G, Cancian M, Chiesa M, Cremonesi P, et al. Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts. Intern Emerg Med. 2014b;9(1):85–92. https://doi.org/10.1007/s11739-013-0993-z.
Craig T, Aygören-Pürsün E, Bork K, Bowen T, Boysen H, Farkas H, et al. WAO guideline for the management of hereditary angioedema. World Allergy Organ J. 2012;5(12):182–99. https://doi.org/10.1097/WOX.0b013e318279affa.
Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. 2009;15(2):69–78. https://doi.org/10.1016/j.molmed.2008.12.001.
Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006;343(4):1286–9. https://doi.org/10.1016/j.bbrc.2006.03.092.
Frémeaux-Bacchi V, Guinnepain MT, Cacoub P, Dragon-Durey MA, Mouthon L, Blouin J, et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med. 2002;113(3):194–9.
Gelfand JA, Boss GR, Conley CL, Reinhart R, Frank MM. Acquired C1 esterase inhibitor deficiency and angioedema: a review. Medicine (Baltimore). 1979;58(4):321–8.
Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139(3):379–94. https://doi.org/10.1111/j.1365-2249.2005.02726.x.
Kaplan AP, Joseph K. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010;104(3):193–204. https://doi.org/10.1016/j.anai.2010.01.007.
Koide M, Shirahama S, Tokura Y, Takigawa M, Hayakawa M, Furukawa F. Lupus erythematosus associated with C1 inhibitor deficiency. J Dermatol. 2002;29(8):503–7.
Kusuma A, Relan A, Knulst AC, Moldovan D, Zuraw B, Cicardi M, et al. Clinical impact of peripheral attacks in hereditary angioedema patients. Am J Med. 2012;125(9):937.e17–24. https://doi.org/10.1016/j.amjmed.2011.12.016.
Longhurst HJ, Tarzi MD, Ashworth F, Bethune C, Cale C, Dempster J, et al. C1 inhibitor deficiency: 2014 United Kingdom consensus document. Clin Exp Immunol. 2015;180(3):475–83. https://doi.org/10.1111/cei.12584.
Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc. 2010;31(5):407–14. https://doi.org/10.2500/aap.2010.31.3394.
Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, Heller C, Klingebiel T, Kreuz W. Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. Am J Obstet Gynecol. 2010;203(2):131.e1–7. https://doi.org/10.1016/j.ajog.2010.03.003.
Matesic D, Fernández Pérez ER, Vlahakis NE, Hagan JB. Acute pancreatitis due to hereditary angioedema. Ann Allergy Asthma Immunol. 2006;97(5):611–4.
Nzeako UC, Longhurst HJ. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema. Eur J Gastroenterol Hepatol. 2012;24(4):353–61. https://doi.org/10.1097/MEG.0b013e3283517998.
Ohsawa I, Nagamachi S, Suzuki H, Honda D, Sato N, Ohi H, et al. Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema. BMC Gastroenterol. 2013;13:123. https://doi.org/10.1186/1471-230X-13-123.
Palazzi C, D’Amico E, Cacciatore P, Pennese E, Olivieri I. Non-rheumatoid erosive arthritis associated with type I hereditary angioedema. Clin Rheumatol. 2005;24(6):632–3. https://doi.org/10.1007/s10067-005-1097-6.
Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A, et al. Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. J Allergy Clin Immunol. 2000;106(6):1147–54. https://doi.org/10.1067/mai.2000.110471.
Prada AE, Zahedi K, Davis AE. Regulation of C1 inhibitor synthesis. Immunobiology. 1998;199(2):377–88. https://doi.org/10.1016/S0171-2985(98)80042-9.
Reshef A, Prematta MJ, Craig TJ. Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys. Allergy Asthma Proc. 2013;34(3):261–6. https://doi.org/10.2500/aap.2013.34.3663.
Roche O, Blanch A, Caballero T, Sastre N, Callejo D, López-Trascasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol. 2005;94(4):498–503. https://doi.org/10.1016/S1081-1206(10)61121-0.
Tarzi MD, Hickey A, Förster T, Mohammadi M, Longhurst HJ. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema. Clin Exp Immunol. 2007;149(3):513–6. https://doi.org/10.1111/j.1365-2249.2007.03438.x.
Tosi M. Molecular genetics of C1 inhibitor. Immunobiology. 1998;199(2):358–65. https://doi.org/10.1016/S0171-2985(98)80040-5.
Wahn V, Aberer W, Eberl W, Faßhauer M, Kühne T, Kurnik K, et al. Hereditary angioedema (HAE) in children and adolescents – a consensus on therapeutic strategies. Eur J Pediatr. 2012;171(9):1339–48. https://doi.org/10.1007/s00431-012-1726-4.
Zanichelli A, Arcoleo F, Barca MP, Borrelli P, Bova M, Cancian M, et al. A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy. Orphanet J Rare Dis. 2015;10:11. https://doi.org/10.1186/s13023-015-0233-x.
Zuraw BL, Sugimoto S, Curd JG. The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency. J Allergy Clin Immunol. 1986;78(6):1115–20.
Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A, et al. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012;33(Suppl 1):S145–56. https://doi.org/10.2500/aap.2012.33.3627.
Zuraw BL, Banerji A, Bernstein JA, Busse PJ, Christiansen SC, Davis-Lorton M, et al. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2013;1(5):458–67. https://doi.org/10.1016/j.jaip.2013.07.002.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Maru, S., Craig, T. (2018). Hereditary Angioedema. In: Craig, T., Ledford, D. (eds) Allergy and Asthma. Springer, Cham. https://doi.org/10.1007/978-3-319-58726-4_10-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-58726-4_10-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58726-4
Online ISBN: 978-3-319-58726-4
eBook Packages: Springer Reference MedicineReference Module Medicine